MediFind

Find a Doctor

Luc Mouthon

Société Nationale Française De Médecine Interne (Snfmi)
Internal Medicine
Male

Bio


They have been an author on 447 peer reviewed articles in the past 15 years. Dr. Mouthon's top three areas of expertise are Scleroderma, Eosinophilic Granulomatosis with Polyangiitis, and Granulomatosis with Polyangiitis.

Contact

FR

Latest Research


Latest Advance
Study
  • Condition: Covid-19 pneumonia
  • Journal: BMJ (Clinical research ed.)
  • Treatment Used: Hydroxychloroquine
  • Number of Patients: 181
  • Published —
The study researched the use of Hydroxychloroquine for patients with Covid-19 pneumonia who need oxygen.
Latest Advance
Study
  • Condition: (ANCA)-Associated Vasculitides
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Rituximab-Based or Azathioprine-Based Maintenance Regimens
  • Number of Patients: 115
  • Published —
This study compared the long-term effectiveness of remission-maintenance regimens in patients with newly diagnosed or relapsing antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides.
Latest Advance
Study
  • Condition: ANCA-Associated Vasculitis Remission
  • Journal: Annals of the rheumatic diseases
  • Treatment Used: Individually Tailored vs. Fixed-Schedule Rituximab Regimen
  • Number of Patients: 162
  • Published —
This study compared individually tailored, based on trimestrial biological parameter monitoring, to fixed-schedule rituximab reinfusion for remission maintenance of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (inflammation of blood vessels; AAVs).

Clinical Trials


This doctor has not participated in any recent clinical trials.

Contact

FR

Insurance

Contact them to find out if they accept your insurance plan.